This just came into my email inbox:
"Dong-A PharmTech Co., Ltd. [a Korean drug company] announced today that it has completed a 340 patient phase 2b 'at-home' clinical study for udenafil, its new long acting (12 hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction (ED)."
See press release.
Does anyone else find this amusing?
Good grief Mr Mack!
ReplyDeleteHow puerile can your humor get?
Please cease and desist!!
Kind regards
http://www.yesicanusechopsticks.com/thesequel/photos/DongMen.jpg
I think you have been reading PharmaGiles again...
ReplyDelete